pantoprazole has been researched along with Aging in 5 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| " No studies have yet compared the effects of different dosages of clarithromycin in combination with a proton pump inhibitor and amoxicillin in elderly patients." | 2.70 | Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. ( Bozzola, L; Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Rassu, M; Soffiati, G; Valerio, G, 2001) |
| " If two drugs of the same class have a similar dose-efficacy profile, then the favourable/unfavourable balance of the pharmacokinetic characteristics of the drugs may determine the drug of choice." | 2.39 | Pharmacokinetics--a relevant factor for the choice of a drug? ( Benet, LZ; Zech, K, 1994) |
| " Pantoprazole pharmacokinetic parameters appear to be similar in pediatric patients compared to adults when allometrically scaled." | 1.37 | Population pharmacokinetic modeling of pantoprazole in pediatric patients from birth to 16 years. ( Comer, G; Gastonguay, MR; Knebel, W; Meng, X; Tammara, B; Udata, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menger, MM | 1 |
| Bremer, P | 1 |
| Scheuer, C | 1 |
| Rollmann, MF | 1 |
| Braun, BJ | 1 |
| Herath, SC | 1 |
| Orth, M | 1 |
| Später, T | 1 |
| Pohlemann, T | 1 |
| Menger, MD | 1 |
| Histing, T | 1 |
| Knebel, W | 1 |
| Tammara, B | 1 |
| Udata, C | 1 |
| Comer, G | 1 |
| Gastonguay, MR | 1 |
| Meng, X | 1 |
| Benet, LZ | 1 |
| Zech, K | 1 |
| Pilotto, A | 2 |
| Di Mario, F | 2 |
| Franceschi, M | 2 |
| Leandro, G | 2 |
| Battaglia, G | 1 |
| Germanà, B | 1 |
| Marin, R | 1 |
| Valerio, G | 2 |
| Bozzola, L | 1 |
| Rassu, M | 1 |
| Soffiati, G | 1 |
1 review available for pantoprazole and Aging
| Article | Year |
|---|---|
Pharmacokinetics--a relevant factor for the choice of a drug?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aging; Benzimidazoles; Biological Ava | 1994 |
2 trials available for pantoprazole and Aging
| Article | Year |
|---|---|
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Aging; Amoxicillin; Anti-Bacterial Agent | 2000 |
Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Aged, 80 and over; Aging; Amoxi | 2001 |
2 other studies available for pantoprazole and Aging
| Article | Year |
|---|---|
Pantoprazole impairs fracture healing in aged mice.
Topics: Aging; Animals; Bone Morphogenetic Protein 4; Disease Models, Animal; Fracture Healing; Mice; Neovas | 2020 |
Population pharmacokinetic modeling of pantoprazole in pediatric patients from birth to 16 years.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Aging; Aryl Hydrocarbon H | 2011 |